HAYDE BOLANOS: Open Payments
NPI 1588059711 · PASSAIC, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,317 in 137 payments from 17 companies in 2025. Trend: 2023 $1,355 · 2024 $1,783 · 2025 $3,317
Food & beverage: $3,206Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 24 | $646 |
| Alkermes, Inc. | 19 | $469 |
| Otsuka America Pharmaceutical, Inc. | 28 | $446 |
| Madrigal Pharmaceuticals | 2 | $268 |
| Lundbeck LLC | 15 | $263 |
| Axsome Therapeutics, Inc. | 5 | $185 |
| E.R. Squibb & Sons, L.L.C. | 10 | $167 |
| Janssen Pharmaceuticals, Inc | 17 | $163 |
| Penumbra, Inc. | 1 | $126 |
| Corcept Therapeutics | 1 | $125 |
Products named: ABILIFY ASIMTUFII, ARISTADA, UZEDY, REZDIFFRA, Auvelity, INVEGA SUSTENNA, AUSTEDO XR, COBENFY.
Industry payments across NJ — which companies pay providers there.
